# Wave Life Sciences Ltd. (WVE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Wave Life Sciences Ltd.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/WVE/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-073472 (https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/WVE/mda/fy2024/): filed 2025-03-04; accession 0000950170-25-031322 (https://www.sec.gov/Archives/edgar/data/1631574/000095017025031322/wve-20241231.htm)
- [FY 2023 MD&A](/company/WVE/mda/fy2023/): filed 2024-03-06; accession 0000950170-24-026876 (https://www.sec.gov/Archives/edgar/data/1631574/000095017024026876/wve-20231231.htm)
- [FY 2022 MD&A](/company/WVE/mda/fy2022/): filed 2023-03-23; accession 0000950170-23-009319 (https://www.sec.gov/Archives/edgar/data/1631574/000095017023009319/wve-20221231.htm)
- [FY 2021 MD&A](/company/WVE/mda/fy2021/): filed 2022-03-03; accession 0001564590-22-008414 (https://www.sec.gov/Archives/edgar/data/1631574/000156459022008414/wve-10k_20211231.htm)

Back to /company/WVE/